Skip to main content
Premium Trial:

Request an Annual Quote

Shareholder Sues to Stop Merck KGaA's $17B Acquisition of Sigma-Aldrich

NEW YORK (GenomeWeb) – A shareholder has filed a lawsuit to stop Merck KGaA's proposed $17 billion buy of Sigma-Aldrich, Shareholders Foundation, a legal monitoring and settlement claim filing service, said today.

According to Shareholders Foundation, the unnamed plaintiff alleges that the $17 billion price tag undervalues Sigma-Aldrich. In a statement, Shareholders Foundation cited as proof Sigma-Aldrich's claim that its total revenues for 2013 increased to more than $2.70 billion from $2.27 billion in 2010. It further noted that the company's net income during the same period increased to $491 million from $384 million.

Under the terms of the deal, Merck KGaA would pay $140 for each outstanding share of Sigma-Aldrich, which would represent a 37 percent premium to Sigma-Aldrich's closing stock price of $102.37 on Sept. 19, the last trading day before the deal was announced.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.